An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome

International Clinical Psychopharmacology

Volumn 12, Issue 1, 1997, Pages 47-52

  White, P D ^a   Cleary, K J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Antidepressant; Chronic fatigue syndrome; Major depressive disorder; Moclobemide; Sleep disorders; Treatment

Indexed keywords

MOCLOBEMIDE;

ADULT; ADVERSE DRUG REACTION; ANOREXIA; ANXIETY NEUROSIS; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; MALE; NAUSEA; PRIORITY JOURNAL; SLEEP DISORDER; SOMNOLENCE; XEROSTOMIA;

EID: 0030892268     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199701000-00007     Document Type: Article

References (28)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders: Revised Version (DSM-III-R). American Psychiatric Association, Washington.
2. Barsky AJ, Goodson JD, Lane RS and Cleary PD (1988) The amplification of somatic symptoms. Psychosomatic Medicine, 50, 510-519.
3. Buchwald DR, Pascualy R, Bombardier C and Kith P (1994) Sleep disorders in patients with chronic fatigue. Clinical Infectious Diseases, 18 (suppl 1), S68-S72.
4. Buysse DJ, Reynolds CF, Monk TH, Berman SR and Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research, 28, 193-213.
5. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D and Wallace EP (1993) Development of a fatigue scale. Journal of Psychomatic Research, 37, 147-153.
6. Davidson JRT, Miller RD, Turnbull CD, Sullivan JL (1982) Atypical depression. Archives of General Psychiatry, 39, 527-534.
7. Goodnick PJ and Sandoval R (1993) Psychotropic treatment of chronic fatigue syndrome and related disorders. Journal of Clinical Psychiatry, 54, 13-20.
8. Gorensek MJ (1991) Chronic fatigue and depression in the ambulatory patient. Primary Care, 18, 397-419.
9. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, pp. 21-222 National Institute of Mental Health, U.S. Department of Health, Education and Welfare publication ADM. Rockville, MD.
10. Hamilton M (1967) Development of a rating scale for primary depressive illness. British Journal of the Society of Clinical Psychology, 6, 278-296.
11. Lynch S, Seth R and Montgomery S (1991) Antidepressant therapy in the chronic fatigue syndrome. British Journal of General Practice, 41, 339-342.
12. McCluskey DR (1993) Pharmacological approaches to the therapy of chronic fatigue syndrome. In Chronic Fatigue Syndrome. CIBA Symposium 173 (Eds GR Bock and J Whelan), pp 280-287. J Wiley & Sons, Chichester.
13. Moll E, Neumann N, Schmid-Burgk W, Stable M and Amrein R (1994) Safety and efficacy during long-term treatment with moclobemide. Clinical Neuropharmacology, 17 (suppl 1), S74-S87.
14. Morriss R, Sharpe M, Sharpley AL, Cowen PJ, Hawton K and Morris J (1993) Abnormalities of sleep in patients with the chronic fatigue syndrome. British Medical Journal, 306, 1161-1164.
15. Natelson BH, Cheu J, Pareja J, Ellis SP, Policastro T and Findley TW (1996) Randomised, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology, 124, 226-230.
16. Norusis MJ (1990) Statistical Package for the Social Sciences PC + 4th ed. SPSS Inc., Chicago.
17. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG and Klein DF (1990) Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Archives of General Psychiatry, 47, 935-941.
18. Royal Colleges (1996) Chronic Fatigue Syndrome: Report of a Joint Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners, pp. 1-58. Royal College of Physicians, London, CR54.
19. Sharpe M (1991) Psychiatric management of PVFS. British Medical Bulletin, 47, 989-1005.
20. Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, Edwards RH, Hawton KE, Lambert HP and Lane RJ (1991) A report - chronic fatigue syndrome: guidelines for research. Journal of the Royal Society of Medicine, 84, 118-121.
21. Spitzer RL, Williams JBW, Gibbon M and First MB (1990) Structured Clinical Interview for DSM III-R. American Psychiatric Press, Washington.
22. Vercoulen JHMM, Swanink CMA, Zitman FG, Vreden SGS, Hoofs MPE, Fennis JFM, Galama JMD, van der Meer JWM and Bleijenberg G (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet, 347, 858-861.
23. Versiani M, Nardi AE, Mundin FD, Alves AB, Liebowitz MR and Amrein R (1992) Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. British Journal of Psychiatry, 161, 353-360.
24. Webb HE and Parsons LM (1991) Chronic post-viral fatigue syndrome: presentation and management in the neurology clinic: In Post-viral Fatigue Syndrome (Eds R Jenkins and JF Mowbray), pp 223-239. J Wiley and Sons, Chichester.
25. Wessely SC (1995) The epidemiology of chronic fatigue syndrome. Epidemiology Reviews, 17, 139-151.
26. White PD, Grover SA, Kangro HO, Thomas JM, Amess J and Clare AW (1995) The validity and reliability of the fatigue syndrome that follows glandular fever. Psychological Medicine, 25, 917-924.
27. Wilson A. Hickie I, Lloyd A, and Wakefield D (1994) The treatment of chronic fatigue syndrome: science and speculation. American Journal of Medicine, 96, 544-550.
28. Zigmond AS and Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370.